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Abstract: The ABA tri-block copolymer poly(2-methyloxazoline)–poly(dimethylsiloxane)–
poly(2-methyloxazoline) (PMOXA–PDMS–PMOXA) is known for its capacity to mimic a bilayer
membrane in that it is able to form vesicular polymersome structures. For this reason, it is the subject
of extensive research and enables the development of more robust, adaptable and biocompatible
alternatives to natural liposomes for biomedical applications. However, the poor solubility of
this polymer renders published methods for forming vesicles unreproducible, hindering research
and development of these polymersomes. Here we present an adapted, simpler method for the
production of PMOXA–PDMS–PMOXA polymersomes of a narrow polydispersity (45 ˘ 5.8 nm),
via slow addition of aqueous solution to a new solvent/polymer mixture. We then magnetically
functionalise these polymersomes to form magnetopolymersomes via in situ precipitation of
iron-oxide magnetic nanoparticles (MNPs) within the PMOXA–PDMS–PMOXA polymersome core
and membrane. This is achieved using electroporation to open pores within the membrane and to
activate the formation of MNPs. The thick PMOXA–PDMS–PMOXA membrane is well known to be
relatively non-permeable when compared to more commonly used di-block polymer membranes
due a distinct difference in both size and chemistry and therefore very difficult to penetrate using
standard biological methods. This paper presents for the first time the application of electroporation
to an ABA tri-block polymersome membrane (PMOXA–PDMS–PMOXA) for intravesicular in situ
precipitation of uniform MNPs (2.6 ˘ 0.5 nm). The electroporation process facilitates the transport
of MNP reactants across the membrane yielding in situ precipitation of MNPs. Further to differences
in length and chemistry, a tri-block polymersome membrane structure differs from a natural lipid
or di-block polymer membrane and as such the application and effects of electroporation on this
type of polymersome is entirely novel. A mechanism is hypothesised to explain the final structure
and composition of these biomedically applicable tri-block magnetopolymersomes.
Keywords: ABA tri-block co-polymer; polymersomes; magnetic nanoparticles; electroporation;
biomedicine; bioinspired
1. Introduction
Vesicles are micro or nano scale chambers of solution, encapsulated by lipid (liposomes) or
polymer (polymersomes). Liposomes specifically are ubiquitous in nature, serving numerous inter
and intra cellular functions. Both liposomes and polymersomes are currently used in multiple
industrial applications, particularly within the medical, food and cosmetics industries [1–3]. Perhaps
the most prominent of these sectors, and with the greatest potential for application, is biomedicine,
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where vesicles have shown particular promise as drug delivery vehicles [4–6]. Vesicles can be used to
encapsulate drugs and then later release them at the target location in response to specific stimuli by
engineering of the vesicle membrane [7,8]. This targeted delivery means that lower doses of drugs can
be administered, significantly improving the treatment efficiency whilst simultaneously reducing the
magnitude and severity of any side effects. Currently, medical researchers are developing therapies
that can simultaneously diagnose and treat a wide range of diseases, termed theranostic agents [9,10].
Theranostics are typically vesicles which incorporate therapeutics (via encapulation of a drug into
a delivery vehicle) and diagonstic tools, such as fluorophores for optical imaging or magnetic
nanoparticles (MNPs) for magnetic resonance imaging (MRI) [3,11–15]. The incorporation of MNPs
means that vesicles can be used for magnetic targeted delivery of therapies, and allow monitoring via
magnetic resonance imaging, as well as opening up treatment options such as magnetic hyperthermic
ablation of tumours [13,14].
Polymersomes are finding new applications across the entire field of biomedicine. The literature
demonstrates that polymersomes can be engineered to incorporate a wide range of properties
designed to meet the requirements of a specific application [15–17]. Polymersomes are already
offering superior properties as drug delivery vehicles when compared with more traditional lipid
vesicles. For example, polymer vesicles can have increased stability and low permeability, and
properties such as increased molecular weight, makes them highly tunable. For instance, di-block
polymer drug delivery carriers have been engineered to respond to stimuli including changes in;
temperature, ionic strength, pH and even light (UV), all of which have huge potential for the
successful release of cargo in many drug delivery applications [6–8,16,18,19]. pH can also control of
the orientation of the polymer during assembly to determine which of the polymer blocks make up
the outer leaflet of the polymersome [6,18]. The molecular weight of a polymer (of each block and also
number of blocks) is fully controlled during its synthesis and has a direct effect on the hydrophobic
thickness of the resulting membrane. This then subsequently impacts on the polymersome’s stability,
fluidity and diffusion properties [1,3,16,20–22]. Therefore it is entirely possible to adapt or engineer
the polymer building blocks, and thus the resulting polymersome, to closer suit the needs of its
eventual application. It is also possible to functionalise a polymersome membrane with a variety
of biological moieties for drug delivery applications, as has been excellently outlined in the review by
Pawar et al. [23]. These molecules include; antibodies, peptides, carbohydrates and small organic
molecules; the choice of which is dependent upon the in vivo target. This functionalisation can
be carried out by either covalent or non-covalent methods, depending on the chemistry of the
polymer used to form the vesicle [23]. Reviewing this area of research highlights the high level of
adaptability that polymersomes can offer, in terms of their susceptibility to engineering a wide range
of functionalisation, and their potential for applications in biomedicine. This makes polymersomes
an excellent material for use in the production of smarter nanomedical vehicles, as there is the ability
to control the in vivo response, solubility, permeability, surface topology and lifetime of the vesicles in
a tunable manner [1,3].
1.1. Poly(2-methyloxazoline)–poly(dimethylsiloxane)–poly(2-methyloxazoline)
(PMOXA–PDMS–PMOXA) Polymersomes
Many polymersomes, with varying composition and properties, have been explored for
their drug delivery capabilities [22]. Most of these studies use AB di-block copolymers, resulting
in di-block polymersomes becoming widely applied in biomedicine. However, ABA tri-block
polymersomes may offer further advantages, particularly with respect to controlling membrane
transport and encapsulation. Advantages of using a tri-block for compartmentalisation of a
reaction include their low permeability (5.7 µm¨ s´1¨ bar´1 for a tri-block polymer compared to
0.22 µm¨ s´1¨ bar´1 for a di-block polymer) [24]. This lower permeability is due to an increased
degree of polymerisation, and the distinctly different chemistries of each block when comparing
the di- and tri-block polymers, such as the addition of end group reactivity in the case of
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PMOXA–PDMS–PMOXA. All of these factors contribute to the formation of a relatively impermeable
polymer membrane (compared to the di-block polymer [24]). The key factor for this study is the
monomeric nature of the resulting membrane, forming an amphiphilic monolayer as opposed to
a more traditional bilayer, upon assembly. We predict that this, along with the increased block
length will lead to significant differences in the rearrangement of the membrane to open pores. This
change in chemistry, degree of polymerisation and membrane structure should give rise to better
encapsulation and maintenance of the polymersome core contents (due to decreased permeability),
along with the ability to stabilise and functionalise the vesicle by adaptation of reactive end groups.
This functionality is particularly beneficial in biomedical applications, where confidence that the
encapsulant will not easily leak out is paramount. Post formation functionalisation of the outer
polymersome membrane can allow the attachment of drug and/or biomolecule therapies for targeted
delivery. In this study we have chosen to explore the nanoreactor capabilities of the ABA tri-block
polymer, PMOXA–PDMS–PMOXA.
A number of groups have studied this ABA tri-block polymer. Dinu et al. utilised the low
permeability of the PMOXA–PDMS–PMOXA polymersome membrane to selectively polymerise the
inner membrane exclusively [25]. PMOXA–PDMS–PMOXA has perhaps been most extensively
studied by the group of Wolfgang Meier [26–30]. Their studies include the assessment of
polymersome formation, controlling the permeability of the polymer vesicles, and the polymerisation
of the individual block copolymers to form networks. Nardin et al. have demonstrated the use of
PMOXA–PDMS–PMOXA vesicle synthetic membranes by successful incorporation of a functional
enzyme into the vesicle for the potential improvement of genetic disorder treatments [27].
Specifically, the treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
by encapsulation of the enzyme using a nucleoside-specific porin (Tsx) has been described
by Vocht et al. [31]. These studies have provided excellent proof of concept work for the use
of PMOXA–PDMS–PMOXA polymersomes as vesicles for biomedicine. This also shows that
PMOXA–PDMS–PMOXA is an ideal candidate for our investigation presented here, where we use an
in situ MNP precipitation reaction to make magnetised polymersomes, and highlight their potential
for use as magnetised biomedical vesicles.
PMOXA–PDMS–PMOXA polymersomes have been shown previously to be inherently
biocompatible, which makes them excellent vehicles for future biomedical theranostic
applications [3]. The presence of methacrylate groups at either end of the polymer (confirmed
by NMR (Figure S1)), and gives rise to extensive polymerisation between individual copolymers
via a chemical initiator, such as a photochemical reaction or irradiation with UV light [26].
On polymerisation of the methacrylate end groups, the polymer becomes covalently linked to
neighbouring polymers, causing stretching of the polymer unit, in particular the hydrophobic region.
This leads to a decrease in permeability and the eventual formation of extended structural networks
within the vesicular membrane, making the polymersomes highly stable and robust (e.g., to changes
in temperature) [29].
1.2. Forming Magnetopolymersomes
Combining MNPs with polymersomes to form magnetopolymersomes has so far been produced
by loading pre-synthesised MNPs into a di-block co-polymer (such as PGA-b-PTMC) vesicle. These
vesicles have also been loaded with anti-cancer drugs, and the resulting theranostic agent shows
enhanced MRI contrast properties as well as successful magnetic targeting and drug delivery [32].
However, these promising magnetopolymersome biomedical agents are formed via a multistep
process of crystallising and processing MNPs pre-vesicle formation, followed by their subsequent
loading into polymersome [32], a process that is inefficient, expensive and time-consuming.
There are numerous ways to synthesise iron-oxide MNPs, many of which result in particles
with differing sizes and shapes, which is highly undesirable [33]. Room temperature co-precipitation
of iron-oxide MNPs (by addition of base to raise the pH of a mixed valence iron solution under
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an inert atmosphere) is simple, but results in a heterogeneous population of MNPs, which must be
size filtered and magnetically separated before use. Methods that produce more mono-dispersed
populations require more complex and costly synthesis and processing procedures. These often
require high temperatures and toxic reagents, adding yet more synthetic steps to process MNPs before
they can be considered suitable for biomedical application. Therefore a greener and milder synthetic
route to making magnetically functionalised polymersomes with high quality mono-dispersed MNP
populations remains an important challenge.
Bioinspired synthesis of magnetopolymersomes could enhance their properties and improve
their function, particularly in the field of bio-nanomedicine. Nature performs precise reactions on
the nanoscale by compartmentalising them within liposomes. Mimicking these systems has inspired
the design of many small-scale synthetic reaction systems termed “nanoreactors” [34]. The concept
of applying a biomimetic approach to the design and synthesis of a functional polymersome has
been previously outlined both by our own group [34] and by Marguet et al. [35]. Here we take our
inspiration from magnetotactic bacteria, which are able to perform controlled biomineralisation of
magnetite MNPs within internal liposomes. Inmagnetotactic bacteria, iron ions cross the membrane
into the vesicle interior via transmembrane iron-transport proteins, yielding the precipitation of
magnetite within the vesicle core [36–38]. Here we adopt a similar strategy, where, for the first time,
we use pre-formed NaOH filled (PMOXA–PDMS–PMOXA) vesicles as a nanoreactor for magnetite
precipitation using electroporation to import iron ions.
Electroporation is a widely used technique in molecular biology to introduce DNA into a host
cell. The application of an electric potential across a cell membrane causes temporary pores to
form. This is because the electric field induces a transmembrane potential difference, which causes
local defects that form pores. We have recently shown that this technique can be used for the
inorganic precipitation of iron oxide nanoparticles in a nanoreactor vesicle arrangement [18]. This
electroporation technique is also currently being explored as a method of getting drugs into delivery
vesicles and for tumour ablation in vivo [39].
Although the mechanism of electroporation is largely unknown (mainly due to the short time
scales and difficulty in probing pore formation), polymersome are believed to undergo similar
poration to that observed in natural lipid cell membranes [40]. Furthermore, there are multiple
parameters which can affect the outcome of electroporation. Most notable is the voltage applied
across the membrane, but factors including path length of the cuvette, sample volume, temperature,
pulse length and number of pulses can also be important. Studies of changes in phospholipid head
group configuration via P-NMR, and observed changes in the vesicle structure has suggested possible
mechanisms for electroporation [41]. Furthermore, molecular dynamics studies have offered multiple
hypotheses regarding electroporation mechanisms [42–44]. However, it has not been possible to prove
these hypotheses experimentally. There are two distinct theories on what is believed to happen when
an electric potential is applied to a membrane. Both mechanisms propose that distortions in the
membrane result in water penatration through a spontaeously formed unfavourable hydrophobic
pore. The lipids then rearrange to form a stable more long-lived hydrophilic pore. This pore grows in
size and is stabilised by a drop in field, causing a decrease in the conductance. The pore formation is
then reversible and reseals over time, with the pore size, stability and/or lifetime being dependant on
the surrounding pressure, the field strength and pulse time, as well as the membrane material [45].
The two mechanisms differ in how the distortions occur in the membrane.
The most widely accepted hypothesis; the transient aqueous pore formation mechanism,
proposes an electric field-induced local distortion and rearrangment of the lipids due to conduction
by the polar head groups. However, this has been disputed as electroporation is also effective in
membranes that contain no polar (i.e., neutral) head groups. The alternative hypothesis: the water
wire mechanism, involves alignment of the water/membrane interface, which undulates with the
current. This results in a disortion, allowing water to pentatrate. However, it cannot be assumed that
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a tri-block polymer membrane will react to the application of an electric field in the same manner as
that of a traditional bilayer.
We know from previous studied that pores can form in the PMOXA–PDMS–PMOXA 2D
suspended membrane [29]. However, the difference in geometry and stability between a suspended
membrane and a polymersome means that they are not entirely comparable. It is reasonable to
believe that the generally accepted theories of electroporation, (both the transient aqueous pore
mechanism [45–47] and the water wire mechanism [48]) could also be responsible for membrane pore
formation in tri-block polymersomes. An ABA tri-block polymersome differs from previously studied
di-block models significantly, in block length, monomer chemistry and the nature by which it forms
a membrane. We believe that this study will both further advance the use of magnetopolymersomes
in biomedicine and also help to inform the mechanism of electroporation in polymersomes.
2. Experimental Section
2.1. Generation of PMOXA–PDMS–PMOXA Polymersomes
All reagents were purchased from Sigma Aldrich, St. Louis, MO, USA. Control
PMOXA–PDMS–PMOXA polymersomes were produced according to the method published by
Nardin et al. [26] in the presence of excess ethanol as it was not possible to obtain the published
17% w/v of the polymer. Our new method of polymersome production consists of dissolving the
PMOXA–PDMS–PMOXA polymer (5 mg, from Polymer Source Inc., Dorval (Montreal), QC, Canada)
in a minimum volume of chloroform and adding this to a round bottom flask; containing a stirrer
bar placed over a stirrer plate. NaOH (5 mL, 10 mM) is added to the polymer/solvent system using
a Harvard Apparatus 11 Plus syringe pump driver at a rate of 5 µL¨min´1. On addition of NaOH,
the solution undergoes phase separation due to the presence of the solvent (CHCl3). To enhance
phase separation and remove polymer precipitate, the sample is transferred to a centrifuge and
spun at 10,000 rpm, for 10 min in a Megafuge 40R (Thermo Scientific, Waltham, MA, USA) using
a swinging bucket rotor (75003607, Thermo Scientific, Waltham, MA, USA). The aqueous layer
containing PMOXA–PDMS–PMOXA polymersomes is isolated and cleaned up to remove excess
NaOH solution using size exclusion chromatography (SEC) (PD-10 size exclusion column (GE
Healthcare, Buckinghamshire, UK)). This is re-suspended in phosphate buffered saline (PBS) (NaCl
(8.0 g, 0.137 mol), KCl (0.20 g, 2.68 ˆ 10´3 mol), Na2HPO4¨ 2H2O (1.44 g, 8.09 ˆ 10´4 mol) and
KH2PO4 (0.240 g, 1.76 ˆ 10´3 mol), dissolved in milliQ water (1 L)) solution to maintain effective salt
concentration across the polymer membrane.
2.2. In Situ Synthesis of Magnetic Nanoparticles
For the precipitation of the iron oxide nanoparticles within the ABA polymer membrane, solutions
of FeCl2¨ 4H2O (1.98 ˆ 10´2 g, 1.00 ˆ 10´4 mol) and FeCl3¨ 6H2O (2.70 ˆ 10´2 g, 1.00 ˆ 10´4 mol)
are each dissolved in degassed water (10 mL). The two solutions are then combined in the
stoichiometric ratio for the precipitation of iron oxide, at a v/v ratio of 1:2 Fe(II):Fe(III). Polymersomes
of PMOXA–PDMS–PMOXA are then added to the iron solution in a 1:1 v/v ratio polymersome:iron
solution. Polymersomes (at a concentration of 1 mg¨mL´1) are electroporated (using a Micropulser™,
BioRad, Hertfordshire, UK) in aliquots of 200 µL, in a cuvette with a maximum volume of 800 µL.
Cuvettes are cooled on ice before application of the voltage, and the solution is re-dispersed by
shaking to prevent sedimentation. A pulse voltage of 750 V is applied to the sample (5 pulses, pulse
length of 2 ms). After application of all 5 pulses, magnetopolymersomes are cleaned up using SEC.
MNP precipitation is confirmed by TEM imaging.
2.3. Ion Transport by a Natural Ionophore
Divalent cationic ionophore A23187 (Sigma Aldrich, St. Louis, MO, USA) is added to a
solution of PMOXA–PDMS–PMOXA polymersomes encapsulating 10 mM NaOH. The ionophore
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(used as provided) is added to a 10 mg¨mL´1 polymersome solution at a ratio of 1% v/v
ionophore:polymersome solution. Iron solution identical to that used for electroporation is added
to the sample, and incubated for 12–24 h. This should allow time for the ionophore to transport iron
ions across the polymersome membrane to precipitate magnetic nanoparticles. Samples are imaged
on TEM to look for the presence of iron oxide within the polymersome.
2.4. Transmission Electron Microscopy
Polymersomes (before and after electroporation) were imaged using a FEI Tecnai G2 Spirit
transmission electron microscope. Before imaging, 5 µL of the polymersome sample was spotted on to
carbon coated copper EM grids. After incubation for approximately 2 min, excess sample was blotted
off using filter paper, and the grids dried under vacuum. For non-electroporated polymersome
samples, a 0.75% uranyl formate stain (to enhance polymersome contrast) was applied for 15 s, before
again blotting and drying under vacuum. Images were recorded using a Gatan 4000ˆ 4000 resolution
charge coupled device (CCD) camera (Gatan, Pleasanton, CA, USA ), and processed using both Gatan
micrograph and ImageJ software (National Institute of Health, Bethesda, MD, USA). Cryo-electron
microscopy was performed on holey carbon grids prepared using 5 µL of polymersome sample.
The grids were subsequently blotted for 3 s (at 100% humidity) and plunged into liquid ethane
using a Vitrobot mark III. Samples were visualised on a Philips CM200, fitted with a Gatan
4000 ˆ 4000 resolution CCD camera. All data were collected in low dose mode.
2.5. Dynamic Light Scattering
All measurements were recorded at 20 ˝C using a Zetasizer Nano series instrument (Malvern
Instruments, Malvern, UK) equipped with a 4 mW 633 nm He–Ne laser and an avalanche photodiode
detector. Polymer dispersions were diluted in deionised water to a concentration of 1.0% w/w and
scattered light was detected at an angle of 173˝.
3. Results and Discussion
Here we present a novel yet simple method for the production of stable and relatively
monodisperse PMOXA–PDMS–PMOXA vesicles without the need for any post formation
modifications such as extrusion. Previously, published methods [26] describe dissolving this tri-block
polymer in ethanol solvent at a concentration of 17% by weight, followed by dilution to the critical
aggregation concentration (cac). This published method could not be repeated in our lab, as we
found that the polymer exhibited low solubility in such small solvent volumes, and was even
poorly soluble when an excess volume of ethanol was added. Therefore, an entirely new route was
designed, in which the polymer is dissolved in CHCl3 solvent at a final concentration above the cac of
0.15 ˆ 10´3 g¨mL´1 in water. Addition of aqueous solution at a rate of 5 µL¨min´1 yields phase
separation between the aqueous solution and the chloroform.
Isolation of the aqueous layer via centrifugation yields a solution of polymersomes with an
average size of 45 ˘ 5.8 nm from TEM images (Figure 1a,b), with the presence of small tubular
structures (disregarded in the grainsizing). The corresponding DLS data show an average size of
32 nm for the polymersomes, and a polydispersity index of 0.5 (Figure 1b). This is in agreement with
the TEM data, and yields a narrower dispersity than those observed in previous publications [26].
We compared our novel method with polymersomes prepared via the method developed by
Nardin et al. [26] but with the use of excess ethanol (hence forth referred to as excess ethanol method).
Rather than discrete, spherical polymersomes, TEM of the samples synthesised by this excess ethanol
method [26] shows extensive branched dendritic polymer networks of approximately 1800 nm in
length (Figure 1c), or 800 nm as measured by DLS (Figure 1d). It is probable that the improved,
narrower dispersity obtained by our novel formation route is the result of the slow addition of the
aqueous solution. It is evident from Figure 1c that, when the excess ethanol method [26] is used,
extensive network polymerisation and/or subsequent aggregation is observed. We varied the rate
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of aqueous solution addition from between 5 and 50 µL¨min´1 and observed little difference in the
morphology and size distribution of the polymersomes formed. However, when the aqueous solution
is added rapidly to dilute the sample (i.e., as is specified in the excess ethanol method [26]), we observe
the formation of large scale branched polymer networks (Figure 1c). Therefore, the rate of addition
must be controlled to ensure that polymersomes rather than polymer networks are formed.Polymers 2015, 7, page–page 
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Figure 1. (a)Transmission electron microscopy (TEM) of poly(2-methyloxazoline)–poly(dimethylsiloxane) 
–poly(2-methyloxazoline) (PMOXA–PDMS–PMOXA) polymersome sample produced via the 
adapted slow aqueous addition method; (b) comparison of TEM (Grey bars) grainsizing and Dynamic 
Light Scattering (DLS) (Red bars) sizing data show an average size of 45 nm compared to 32 nm, 
respectively, and a polydispersity index of 0.5; (c) TEM of PMOXA–PDMS–PMOXA polymersomes 
produced via the previously published method with excess ethanol (excess ethanol method) [26] 
shows the presence of polymer networks and (d) the corresponding TEM (Grey bars) and DLS  
(Red Bars) grainsizing showing an average size of 1.8 µm and 800 nm respectively. 
The PMOXA–PDMS–PMOXA polymersomes synthesised by our novel slow addition method 
have been used as a nanoreactor for a room temperature co-precipitation reaction of magnetite MNPs 
within the polymersome membrane. NaOH (10 mM) is used as the aqueous solution for 
polymersome formation to create the high pH environment needed for magnetite precipitation 
within the vesicle core. This is followed by iron ion transport across the PMOXA–PDMS–PMOXA 
polymersome membrane. As discussed above, the successful encapsulation and use of these 
polymersomes as nanoreactors for other purposes has previously been shown by multiple  
groups [25,28,29,31,49,50]. In addition, it is believed that the PMOXA–PDMS–PMOXA membrane 
should behave in a manner analogous to a phospholipid membrane. However, the extended 
hydrophobic region of the polymer results in reduced permeability and a thicker membrane when 
compared to a biological lipid alternative [29]. Therefore, the incorporation of biological processes 
and biomembrane species into these tri-block polymersomes may be unlikely to succeed. As an 
alternative, we employ our recently published method of permeating a polymer membrane using 
electroporation [18]. Electroporation enhances membrane permeability, thus enabling the use of  
the polymersome as a nanoreactor for the precipitation MNPs within the polymersomes (Figure 2). 
Application of an electric potential across the membrane leads to poration, which allows the influx 
and efflux of the iron solution and NaOH magnetite precipitation reagents (respectively). On meeting 
in the membrane (as with our previous magnetopolymersome study [18]), iron oxide MNPs 
precipitate (Figure 2). 
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the polymersome as a nanoreactor for the precipitation MNPs within the polymersomes (Figure 2).
Application of an electric potential across the membrane leads to poration, which allows the influx
and efflux of the iron solution and NaOH magnetite precipitation reagents (respectively). On
meeting in the membrane (as with our previous magnetopolymersome study [18]), iron oxide MNPs
precipitate (Figure 2).Polymers 2015, 7, page–page 
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Figure 2. (a) The formation of iron oxide nanoparticles within tri-block PMOXA–PDMS–PMOXA 
polymersomes as the result of electroporation; (b) an example of a magnetopolymersome (at higher 
magnification) showing the distribution of nanoparticles within the polymersomes; (c) cryogenic 
TEM of magnetopolymersomes (indicated by red arrows in image) with electron density in both  
the polymersome core and within the membrane and of a size (37 ± 9 nm) in agreement with the DLS;  
(d) the change in polymersome size before and after electroporation with unelectroporated control 
polymersomes (striped bars) with an average size of 45 ± 8 nm. After electroporation, a dual 
polymersome population at 20 and 60 nm is observed, giving an average polymersome size of  
43.0 ± 2.4 nm; and (e) the corresponding MNP grainsizing from TEM, showing the average 
electroporated nanoparticle to be 2.6 ± 0.9 nm in diameter. The magnetopolymersome were shown to 
be superparamagnetic by VSM analysis (Figure S4). 
For comparison of transmembrane iron transport, a divalent cation ionophore (A23187) that is 
able to carry ferrous ions across a lipid bilayer membrane [51], was used to test if biological moieties 
are able to insert into and function within the PMOXA–PDMS–PMOXA membrane, and thus to 
transport iron ions into the polymersome core using conventional membrane transport. This proved 
to be unsuccessful (Figure S2), probably because the polymer membrane has an increased thickness 
when compared to a natural lipid membrane. In nature, A23187 would typically be used to span 
membranes of 4–5 nm, which is about half the thickness of the PMOXA–PDMS–PMOXA membrane 
(~10 nm). It is likely that this increased thickness of the polymers negatively impacts on the 
ionophore’s transport capabilities, rendering it far less effective at transporting iron across polymer 
membranes when compared to thinner bi-layer lipid membranes. This aligns well with previous  
studies and suggests that natural methods of permeation are largely unsuccessful on these membranes. 
The tri-block polymersomes are able to withstand voltages that are orders of magnitude  
higher than previously reported values for suspended membranes of PMOXA–PDMS–PMOXA. 
Seven hundred fifty volts were applied to the polymersomes five times (see Experimental Section). 
This is three to five times higher than a previously reported breakdown voltage of 1 ± 0.2 V and  
1.5 ± 0.2 V for tri-block polymersomes following polymerisation [29]. Thus far, we have not observed 
breakdown of the polymersomes after the electric potential has been applied, as cryo-EM confirms 
both the size and morphology of the polymersome (Figure 2c) are maintained after electroporation. 
Post electroporation, tri-block polymersomes have an average size of 43.0 ± 2.4 nm, and only appear 
misshapen in regular TEM (i.e., when dried down rather than cryogenically frozen), which can be 
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DLS; (d) the change in polymersome size before and after electroporation with unelectroporated
control polymersomes (s riped bars) with an averag size of 45 ˘ 8 nm. After el ctrop ration,
a dual polymerso e popula ion at 20 a 60 nm is observed, giving an average polymersome size
of 43.0 ˘ 2.4 nm; and (e) the corresponding MNP grainsizing from TEM, showing the average
electroporated nanoparticle to be 2.6˘ 0.9 nm in diameter. The magnetopolymersome were shown to
be superparamagnetic by VSM analysis (Figure S4).
For comparison of transmembrane iron transport, a divalent cation ionophore (A23187) that
is able to ca ry ferrous i ns across a lipid bilayer membra e [51], was used to test if biological
moieties are able to insert into and function within the PMOXA–PDMS–PMOXA membrane, and
thus to transport iron ions into the poly ersome core using conventional membrane transport. This
proved to be unsuccessful (Figure S2), probably because the polymer membrane has an increased
thickness when compared to a natural lipid membrane. In nature, A23187 would typically be used
to span membranes of 4–5 nm, which is about half the thickness of the PMOXA–PDMS–PMOXA
membrane (~10 nm). It is likely that this increased thickness of the polymers negatively impacts
on the ionophore’s transport capabilities, r ndering it far less ffective at tran portin iron across
polymer membranes when compared to thinner bi-layer lipid membranes. This aligns well with
previous studies and suggests that natural methods of permeation are largely unsuccessful on
these membranes.
The tri-block polymersomes are able to withstand voltages that are orders of magnitude
higher than previously reported values for suspended membranes of PMOXA–PDMS–PMOXA.
Seven hundred fifty volts were applied to the polymersomes five times (see Experimental Section).
This is three to five times higher than a previ usly reported breakdown v ltage of 1 ˘ 0.2 V and
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1.5 ˘ 0.2 V for tri-block polymersomes following polymerisation [29]. Thus far, we have not observed
breakdown of the polymersomes after the electric potential has been applied, as cryo-EM confirms
both the size and morphology of the polymersome (Figure 2c) are maintained after electroporation.
Post electroporation, tri-block polymersomes have an average size of 43.0 ˘ 2.4 nm, and only appear
misshapen in regular TEM (i.e., when dried down rather than cryogenically frozen), which can be
attributed to drying artefacts. The size of cryo-TEM imaged magnetopolymersomes is comparable to
the un-electroporated control polymersomes shown in Figure 1a (i.e., 37 ˘ 9 nm).
On close inspection of the polymersomes (Figure 2), nanoparticles within the polymersome
membrane can be seen. We are confident of the particles’ tight association with the polymersomes,
as they remain bound during the column clean-up process. When these polymersomes particles are
compared to a room temperature co-precipitation of magnetite in the absence of polymersomes, much
bigger, more polydisperse nanoparticles with an average size of 9.3 ˘ 2.7 nm (Figure S3) are formed.
The polymersome associated MNPs are smaller, with an average size of 2.6 ˘ 0.9 nm (Figure 2e)
and show improved monodispersity with regards to particle size and shape when compared to
the room temperature co-precipitation. This distinct difference in particle size and dispersity is
evidence that MNPs associated with the polymersomes have been precipitated in situ, giving rise
to the tighter control observed. Furthermore it appears that the quantity of MNPs increases with
their proximity to the core of the polymersome. TEM and Cryo-EM of the polymersomes confirms
the MNPs position as being within the polymersome membrane (rather than being an aggregation
of MNPs or just associated to the outside of the polymersome through electrostatic interactions)
(Figure 2). Furthermore, the vesicle bilayer is clearly defined in the EM images obtained under
cryogenic conditions.
Electroporated PMOXA–PDMS–PMOXA polymersomes are different to those formed with
lipids and di-block co-polymers, due to the size, structural and chemical reasons discussed. We
believe that this is the reason for an apparent increase in density of MNPs within the core of
the vesicle, grading to fewer particles towards the edge of a vesicle. We thus believe there is a
different mechanism in play in the mineralisation of the tri-block polymersomes when compared
to the di-block and lipid bilayer vesicles. The core of the tri-block magnetopolymersomes appears
to be denser when compared to our previous work using AB di-block co-polymers [18]. It is
likely that this increased density in the tri-block magnetopolymersomes is due to more iron ions
being able to penetrate into the core of the polymersome during electroporation. This would result
in some MNP precipitation within the tri-block polymersome lumen that is not observed in our
study with the di-block co-polymer. This variance is most likely to be due to the difference in the
composition (namely the degree of polymerisation and membrane structure) of the di- and tri-block
polymers, and the effect that this has on the electroporation mechanism. It is possible that the
tri-block vesicles are able to be stabilised during electroporation, possibly due to the difference in
monomer chemistry between the two polymers, causing polymerisation of the methacrylate groups
and stabilising pore formation. It is also a possibility that the increased length of the hydrophobic
region of the polymer and consequently the decreased permeability reduces leakage of NaOH out
of the membrane. This would lead to a higher concentration of reactant being present in the vesicle
core during electroporation. The increased iron ion uptake observed suggests that the electroporation
pore formation and molecular rearrangement of the membrane in a tri-block co-polymer differs from
bilayer arrangements previously reported. Reasons for the difference in iron uptake could include
the stabilisation of the pores due to polymerisation of the reactive end groups during electroporation.
This would allow the formation of more particles in the core of the polymersome. This longer pore
lifetime would allow for increased influx of iron ions across the membrane and a higher chance of
reactants reaching the polymersome core giving rise to the increased MNP density observed in the
polymersome core.
It has previously been proposed by both Lomora [50] and Itel [52] that when forming a
membrane that tri-block polymers could completely double over on itself, in a configuration
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analogous to a “hairpin”, which would render them equivalent to a di-block or lipid, thus assembling
to form a membrane equivalent to a lipid bilayer (as shown by Figure 3b). However, in our polymer
block proportions are 1700:4000:1700 g¨mol´1, meaning the hydrophobic block length is more
than double the hydrophilic block lengths. Therefore, further analysis (e.g., using computational
modelling) would be necessary to determine if it is possible for the PMOXA–PDMS–PMOXA used
in this study, to form a hairpin and behave analogous to a di-block membrane. Our hypothesis is
that the membrane consists of one unit; a single polymer as opposed to two polymers forming a
bilayer. This means that head group rearrangement to form a pore may be restricted (Figure 3).
We propose a mechanism for rearrangement during electroporation, based on this property of
PMOXA–PDMS–PMOXA. We suggest that, due to the flexibility within the tri-block polymer
membrane, the introduction of polar water molecules into the membrane via electroporation causes
the polymer to bend over on itself to shield the hydrophobic region of its structure (Figure 3c). This
comes from both the length of the membrane and its high flexibility.
It is likely that adopting a “bent” configuration would be more entropically favourable than
interactions between the PDMS and water. The increased electron density in the magnetopolymersome,
suggesting increased iron oxide MNP precipitation, may be due to interactions between the reactive
PMOXA end groups on the polymer (Figure 3c) maintaining the pores, or the extreme bending of the
polymer increasing pore size and consequent iron ion influx. Either of these mechanisms could be the
cause of the observed increase in the number of MNPs observed, as well as the greater MNP density
in the core as the pores are retained for longer lifetimes. We aim to test this theory as part of a larger
study of electroporation with tri-block co-polymers with a range of hydrophobic region lengths.
We hypothesise that decreasing the hydrophobic region would reduce polymer flexibility, and thus
the ability to shield the hydrophobic region. This would possibly result in less or no poration, with
high fields resulting membrane breakdown.
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4. Conclusions
This paper presents a simplified method for the synthesis of monodisperse ABA tri-block
polymersomes of PMOXA–PDMS–PMOXA. We have developed this method to produce stable,
monodisperse vesicles without the need for any post formation modifications such as extrusion. We
have demonstrated for the first time a method for synthetic permeation of a tri-block polymersome
membrane by adaptation of our recently reported method of iron transport and iron oxide
precipitation via electroporation [18]. This method is important, as it increases the permeability of
the tri-block polymersome membranes, which is not as readily achieved using a cationic ionophore,
due to the increased membrane thickness when compared to a natural lipid bilayer, making the
incorporation of biological moieties difficult. It has long been thought that incorporation of biological
molecules, such as ion channels and enzymes, are essential for the use of a polymersome as a
nanoreactor and subsequently as biomedical agents. Our simplified electroporation method achieves
greater permeation than that achieved with natural biomolecules (A23187 ionophore) whilst also
offering more control than encapsulating reactants post formation.
Di-block magnetopolymersomes have shown increased diagnostic capabilities when applied to
MRI imaging [18]. Electroporation of the polymer membrane for the in situ synthesis of iron oxide
MNPs offer new vehicles for applications in biomedicine. The advantage of electroporation allows
for the remote precipitation of magnetic nanoparticles. Using a polymer with reactive methacrylate
end groups opens up potential for post formation functionalisation; this could offer a choice between
core encapsulation of drugs during polymersome formation of post formation attachment to the outer
surface of the polymersome, in this polymersome form.
We have observed increased MNP precipitation and demonstrated that the
PMOXA–PDMS–PMOXA polymersomes can withstand electric potentials much higher than previously
reported values for the supported membrane alone. The embedded MNPs are of a higher quality
than standard room temperature co-precipitated MNPs, being both smaller (therefore exclusively
superparamagnetic) and much more monodisperse. We present a new hypothesis for the mechanism
of ABA membrane rearrangement during electroporation. This involves the bending of the
individual polymers to shield the hydrophobic region. We suggest that this is specific to ABA
membranes due to their increased flexibility and nature of their hydrophobic region. We believe
this is the reason for the increased MNP precipitation we see when compared to di-block polymer
magnetopolymersomes [18].
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/2073-4360/
7/12/1529/s1.
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